Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Noa E Wijnen, Joost B Koedijk, Kim Klein, Maaike Luesink, Bianca F Goemans, C Michel Zwaan & Gertjan JL Kaspers. (2023) Treating CD33-Positive de novo Acute Myeloid Leukemia in Pediatric Patients: Focus on the Clinical Value of Gemtuzumab Ozogamicin. OncoTargets and Therapy 16, pages 297-308.
Read now
Read now
Nira Arad-Cohen, Bernward Zeller, Jonas Abrahamsson, Jose Maria Fernandez Navarro, Daniel Cheuk, Sauli Palmu, Vitor Costa, Barbara De Moerloose, Henrik Hasle, Kirsi Jahnukainen, Cornelis Jan Pronk, Ólafur Gísli Jónsson, Zhanna Kovalova, Birgitte Lausen, Monica Munthe-Kaas, Ulrika Noren-Nyström, Josefine Palle, Ramune Pasauliene, Kadri Saks & Gertjan JL Kaspers. (2022) Supportive care in pediatric acute myeloid leukemia:Expert-based recommendations of the NOPHO-DB-SHIP consortium. Expert Review of Anticancer Therapy 22:11, pages 1183-1196.
Read now
Read now
Romy E Van Weelderen, Kim Klein, Meyrina D Natawidjaja, Ralph De Vries & Gertjan JL Kaspers. (2021) Outcome of pediatric acute myeloid leukemia (AML) in low- and middle-income countries: a systematic review of the literature. Expert Review of Anticancer Therapy 21:7, pages 765-780.
Read now
Read now
W H Segerink, V de Haas & G J L Kaspers. (2021) Measurable residual disease in pediatric acute myeloid leukemia: a systematic review. Expert Review of Anticancer Therapy 21:4, pages 451-459.
Read now
Read now
Anne E Hoffman, Linda J Schoonmade & Gertjan JL Kaspers. (2021) Pediatric relapsed acute myeloid leukemia: a systematic review. Expert Review of Anticancer Therapy 21:1, pages 45-52.
Read now
Read now
Articles from other publishers (20)
Katherine Tarlock, Xiaowei Liu, Charles G. Minard, Emasenyie A. Isikwei, Joel M. Reid, Terzah M. Horton, Elizabeth Fox, Brenda J. Weigel & Todd Cooper. (2023) Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712. Pediatric Blood & Cancer 70:12.
Crossref
Crossref
Romy E. van Weelderen, Noa E. Wijnen, Festus Njuguna, Kim Klein, Terry A. Vik, Gilbert Olbara & Gertjan J. L. Kaspers. (2023)
Treatment outcomes of pediatric acute myeloid leukemia in Western Kenya before and after the implementation of the
SIOP PODC
treatment guideline
. Cancer Reports.
Crossref
Crossref
Romy E. van Weelderen, Kim Klein, Christine J. Harrison, Yilin Jiang, Jonas Abrahamsson, Nira Arad-Cohen, Emmanuelle Bart-Delabesse, Barbara Buldini, Barbara De Moerloose, Michael N. Dworzak, Sarah Elitzur, José M. Fernández Navarro, Robert B. Gerbing, Bianca F. Goemans, Hester A. de Groot-Kruseman, Erin Guest, Shau-Yin Ha, Henrik Hasle, Charikleia Kelaidi, Hélène Lapillonne, Guy Leverger, Franco Locatelli, Riccardo Masetti, Takako Miyamura, Ulrika Norén-Nyström, Sophia Polychronopoulou, Mareike Rasche, Jeffrey E. Rubnitz, Jan Stary, Anne Tierens, Daisuke Tomizawa, C. Michel Zwaan & Gertjan J.L. Kaspers. (2023)
Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood
KMT2A
-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group
. Journal of Clinical Oncology 41:16, pages 2963-2974.
Crossref
Crossref
Mohammadreza Bordbar, Nazila Jam, Mehran Karimi, Mahdi Shahriari, Soheila Zareifar, Omid Reza Zekavat, Sezaneh Haghpanah & Hadi Mottaghipisheh. (2023) The survival of childhood leukemia: An 8‐year single‐center experience. Cancer Reports 6:4.
Crossref
Crossref
Jasper J. van de Pol, Maya Schulpen, Bianca F. Goemans, Gertjan Kaspers, Henrike E. Karim-Kos & C. Michel Zwaan. (2023) Outcome of children with relapsed acute myeloid leukemia improved over time in the Netherlands between 1998 and 2018. EJC Paediatric Oncology 1, pages 100010.
Crossref
Crossref
Romy E. van Weelderen, Festus Njuguna, Kim Klein, Saskia Mostert, Sandra Langat, Terry A. Vik, Gilbert Olbara, Martha Kipng'etich & Gertjan J. L. Kaspers. (2021) Outcomes of pediatric acute myeloid leukemia treatment in Western Kenya. Cancer Reports 5:10.
Crossref
Crossref
Qing Wang, Chao Yue, Qin Liu & Xuchun Che. (2022) Exploration of differentially expressed mRNAs and miRNAs for pediatric acute myeloid leukemia. Frontiers in Genetics 13.
Crossref
Crossref
Marianne Agerlund Petersen, Carina Agerbo Rosenberg, Marie Bill, Marie Beck Enemark, Ole Rahbek, Anne Stidsholt Roug, Henrik Hasle, Bent Honoré & Maja Ludvigsen. (2022) Proteomic Profiling Identifies Specific Leukemic Stem Cell-Associated Protein Expression Patterns in Pediatric AML Patients. Cancers 14:15, pages 3567.
Crossref
Crossref
Kim Klein, H. Berna Beverloo, Martin Zimmermann, Susana C. Raimondi, Christine Neuhoff, Valérie Haas, Romy Weelderen, Jacqueline Cloos, Jonas Abrahamsson, Yves Bertrand, Michael Dworzak, Alcira Fynn, Brenda Gibson, Shau‐Yin Ha, Christine J. Harrison, Henrik Hasle, Sarah Elitzur, Guy Leverger, Alexei Maschan, Bassem Razzouk, Dirk Reinhardt, Carmelo Rizzari, Pter Smisek, Ursula Creutzig & Gertjan J. L. Kaspers. (2021) Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study. Pediatric Blood & Cancer 69:1.
Crossref
Crossref
Naveera Zafar, Kulsoom Ghias & Zehra Fadoo. (2020) Genetic aberrations involved in relapse of pediatric acute myeloid leukemia: A literature review. Asia-Pacific Journal of Clinical Oncology 17:5.
Crossref
Crossref
Arianne M. Brandsma, Eline J.M. Bertrums, Markus J. van Roosmalen, Damon A. Hofman, Rurika Oka, Mark Verheul, Freek Manders, Joske Ubels, Mirjam E. Belderbos & Ruben van Boxtel. (2021) Mutation Signatures of Pediatric Acute Myeloid Leukemia and Normal Blood Progenitors Associated with Differential Patient Outcomes. Blood Cancer Discovery 2:5, pages 484-499.
Crossref
Crossref
Hui‐min Zeng, Guan‐hua Hu, Ai‐dong Lu, Yue‐ping Jia, Ying‐xi Zuo & Le‐ping Zhang. (2021) Predictive impact of residual disease detected using multiparametric flow cytometry on risk stratification of paediatric acute myeloid leukaemia with normal karyotype. International Journal of Laboratory Hematology 43:4, pages 752-759.
Crossref
Crossref
Yixin Hu, Aili Chen, Li Gao, Hailong HeShuting Jiang, Xinchang Zheng, Peifang XiaoJun LuYi WangJie LiJianqin LiJunjie FanYanhua YaoJing LingLiyan FanShengqin ChengCheng ChengFang FangJian PanQian-fei Wang, Raul C. Ribeiro & Shaoyan Hu. (2021) Minimally myelosuppressive regimen for remission induction in pediatric AML: long-term results of an observational study. Blood Advances 5:7, pages 1837-1847.
Crossref
Crossref
Wanzi Chen, Jinghui Yang & Ping Chen. (2021) Cytogenetic characteristics of and prognosis for acute myeloid leukemia in 107 children. Asian Biomedicine 15:2, pages 79-89.
Crossref
Crossref
Tariq Ghafoor, Sumaira Khalil, Tanzeela Farah, Shakeel Ahmed & Imtenan Sharif. (2020) Prognostic Factors in Childhood Acute Myeloid Leukemia; Experience from A Developing Country. Cancer Reports 3:5.
Crossref
Crossref
Kim Klein, Raphaële R.L. Litsenburg, Valérie Haas, Natasja Dors, Marry M. den Heuvel‐Eibrink, Rutger R.G. Knops, Wim J.E. Tissing, Birgitta A. Versluys, C. Michel Zwaan & Gertjan J.L. Kaspers. (2019) Causes of early death and treatment‐related death in newly diagnosed pediatric acute myeloid leukemia: Recent experiences of the Dutch Childhood Oncology Group. Pediatric Blood & Cancer 67:4.
Crossref
Crossref
Deepak Bansal, Alan Davidson, Eddy Supriyadi, Festus Njuguna, Raul C. Ribeiro & Gertjan J. L. Kaspers. (2019) SIOP PODC adapted risk stratification and treatment guidelines: Recommendations for acute myeloid leukemia in resource‐limited settings. Pediatric Blood & Cancer.
Crossref
Crossref
Nan Zhang, Ying Chen, Yan Shen, Shifeng Lou & Jianchuan Deng. (2019) Comprehensive analysis the potential biomarkers for the high-risk of childhood acute myeloid leukemia based on a competing endogenous RNA network. Blood Cells, Molecules, and Diseases 79, pages 102352.
Crossref
Crossref
Caroline R.M. Wiggers, Anita M.A.P. Govers, Daphne Lelieveld, David A. Egan, C. Michel Zwaan, Edwin Sonneveld, Paul J. Coffer & Marije Bartels. (2019) Epigenetic drug screen identifies the histone deacetylase inhibitor NSC3852 as a potential novel drug for the treatment of pediatric acute myeloid leukemia. Pediatric Blood & Cancer 66:8.
Crossref
Crossref
A. M. J. Reedijk, K. Klein, J. W. W. Coebergh, L. C. Kremer, A. G. Dinmohamed, V. de Haas, A. B. Versluijs, G. J. Ossenkoppele, H. B. Beverloo, R. Pieters, C. M. Zwaan, G. J. L. Kaspers & H. E. Karim-Kos. (2018) Improved survival for children and young adolescents with acute myeloid leukemia: a Dutch study on incidence, survival and mortality. Leukemia 33:6, pages 1349-1359.
Crossref
Crossref